a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, AIM has been loosely correlated with HOTH. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if AIM jumps, then HOTH could also see price increases.
Ticker / NAME | Correlation To AIM | 1D Price Change % | ||
---|---|---|---|---|
AIM | 100% | -0.76% | ||
HOTH - AIM | 33% Loosely correlated | +1.11% | ||
ELVN - AIM | 28% Poorly correlated | -3.42% | ||
SLN - AIM | 28% Poorly correlated | -8.72% | ||
VRCA - AIM | 24% Poorly correlated | +0.45% | ||
EDSA - AIM | 24% Poorly correlated | +2.84% | ||
More |